{"id":26911,"date":"2024-09-24T09:49:47","date_gmt":"2024-09-24T07:49:47","guid":{"rendered":"https:\/\/ggba.swiss\/novostia-secures-chf-5-6-million-to-accelerate-the-development-of-its-heart-valve\/"},"modified":"2024-09-24T09:51:50","modified_gmt":"2024-09-24T07:51:50","slug":"novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/","title":{"rendered":"Novostia r\u00e9unit CHF 5,6 millions pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa valve cardiaque"},"content":{"rendered":"\n<p><a href=\"https:\/\/www.novostia.com\/\">Novostia<\/a>, une entreprise de technologie m\u00e9dicale bas\u00e9e \u00e0 Lausanne qui d\u00e9veloppe une valve cardiaque artificielle r\u00e9volutionnaire, a obtenu un financement suppl\u00e9mentaire de CHF 5,6 millions. Ce coup de pouce financier permettra \u00e0 l&rsquo;entreprise de faire avancer ses essais cliniques et de pr\u00e9parer sa prochaine phase de financement. La valve TRIFLO de Novostia, actuellement test\u00e9e dans le cadre de l&rsquo;essai clinique PILATUS, vise \u00e0 transformer le traitement des maladies valvulaires aortiques et mitrales en am\u00e9liorant les r\u00e9sultats pour les patients et en r\u00e9duisant les co\u00fbts des soins de sant\u00e9.<\/p>\n\n\n\n<p>Ce nouveau financement intervient \u00e0 un moment crucial pour Novostia, qui s&rsquo;appr\u00eate \u00e0 pr\u00e9senter les premiers r\u00e9sultats de ses essais cliniques lors de la conf\u00e9rence de l&rsquo;Association europ\u00e9enne de chirurgie cardio-thoracique (<a href=\"https:\/\/www.eacts.org\/\">EACTS<\/a>), qui se tiendra \u00e0 Lisbonne en octobre. La valve TRIFLO est con\u00e7ue pour r\u00e9duire la n\u00e9cessit\u00e9 d&rsquo;un traitement anticoagulant \u00e0 vie et pour am\u00e9liorer la qualit\u00e9 de vie des patients gr\u00e2ce \u00e0 une meilleure dynamique du flux sanguin et \u00e0 une plus grande durabilit\u00e9.<\/p>\n\n\n\n<p>En plus du financement, Novostia a annonc\u00e9 un changement de direction avec la nomination de Soad El Ghazouani en tant que CEO, qui succ\u00e8de ainsi \u00e0 Alain Barbal. Avec plus de 25 ans d&rsquo;exp\u00e9rience dans le secteur cardiovasculaire, notamment en tant que cofondatrice et CEO de T-Heart, Soad apporte une grande expertise dans la direction de soci\u00e9t\u00e9s innovantes de dispositifs m\u00e9dicaux \u00e0 croissance rapide. Son expertise devrait guider Novostia dans les prochaines \u00e9tapes du d\u00e9veloppement clinique et commercial.<\/p>\n\n\n\n<p>\u00ab Nous sommes immens\u00e9ment reconnaissants \u00e0 nos investisseurs et \u00e0 nos partenaires pour leur soutien ind\u00e9fectible \u00bb, a d\u00e9clar\u00e9 Alexander Valkenberg, pr\u00e9sident de Novostia. \u00ab Le succ\u00e8s de la lev\u00e9e de fonds et le leadership de Soad marquent un moment charni\u00e8re dans la poursuite de notre mission : l&rsquo;am\u00e9lioration des r\u00e9sultats pour les patients. \u00bb<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Novostia a lev\u00e9 CHF 5,6 millions lors d&rsquo;un nouveau tour de table et nomm\u00e9 Soad El Ghazouani au poste de CEO afin d&rsquo;acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.<\/p>\n","protected":false},"author":6,"featured_media":26908,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1181,1163,1141,1168],"class_list":["post-26911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-medical-devices-fr","tag-medtech-fr-2","tag-personalized-medicine-fr-2","tag-technology-park-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa<\/title>\n<meta name=\"description\" content=\"Novostia a lev\u00e9 CHF 5,6 millions afin d&#039;acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa\" \/>\n<meta property=\"og:description\" content=\"Novostia a lev\u00e9 CHF 5,6 millions afin d&#039;acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2024-09-24T07:49:47+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T07:51:50+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Novostia r\u00e9unit CHF 5,6 millions pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa valve cardiaque\",\"datePublished\":\"2024-09-24T07:49:47+00:00\",\"dateModified\":\"2024-09-24T07:51:50+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\"},\"wordCount\":336,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg\",\"keywords\":[\"Medical Devices\",\"Medtech\",\"Personalized Medicine\",\"Technology Park\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\",\"name\":\"Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg\",\"datePublished\":\"2024-09-24T07:49:47+00:00\",\"dateModified\":\"2024-09-24T07:51:50+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Novostia a lev\u00e9 CHF 5,6 millions afin d'acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"La valve cardiaque TRIFLO de Novostia continue d'\u00eatre prometteuse dans les essais cliniques, tandis que la nouvelle direction guide la prochaine phase de croissance de l'entreprise. | \u00a9 Novostia\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Novostia r\u00e9unit CHF 5,6 millions pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa valve cardiaque\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa","description":"Novostia a lev\u00e9 CHF 5,6 millions afin d'acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/","og_locale":"fr_FR","og_type":"article","og_title":"Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa","og_description":"Novostia a lev\u00e9 CHF 5,6 millions afin d'acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.","og_url":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2024-09-24T07:49:47+00:00","article_modified_time":"2024-09-24T07:51:50+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Novostia r\u00e9unit CHF 5,6 millions pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa valve cardiaque","datePublished":"2024-09-24T07:49:47+00:00","dateModified":"2024-09-24T07:51:50+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/"},"wordCount":336,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg","keywords":["Medical Devices","Medtech","Personalized Medicine","Technology Park"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/","url":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/","name":"Novostia r\u00e9unit CHF 5,6 millions pour sa valve cardiaque | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg","datePublished":"2024-09-24T07:49:47+00:00","dateModified":"2024-09-24T07:51:50+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Novostia a lev\u00e9 CHF 5,6 millions afin d'acc\u00e9l\u00e9rer le d\u00e9veloppement de sa technologie de valve cardiaque TRIFLO.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2024\/09\/Novostia-1180x811-1.jpg","width":1180,"height":811,"caption":"La valve cardiaque TRIFLO de Novostia continue d'\u00eatre prometteuse dans les essais cliniques, tandis que la nouvelle direction guide la prochaine phase de croissance de l'entreprise. | \u00a9 Novostia"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/novostia-reunit-chf-56-millions-pour-accelerer-le-developpement-de-sa-valve-cardiaque\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Novostia r\u00e9unit CHF 5,6 millions pour acc\u00e9l\u00e9rer le d\u00e9veloppement de sa valve cardiaque"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/26911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=26911"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/26911\/revisions"}],"predecessor-version":[{"id":26913,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/26911\/revisions\/26913"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/26908"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=26911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=26911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=26911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}